4/25
10:02 am
vrax
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes [Yahoo! Finance]
Low
Report
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes [Yahoo! Finance]
4/25
08:10 am
vrax
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 [Yahoo! Finance]
Medium
Report
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 [Yahoo! Finance]
4/25
08:00 am
vrax
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
High
Report
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
4/16
07:45 am
vrax
Virax Biolabs to Participate at ESCMID Global 2024 [Yahoo! Finance]
Medium
Report
Virax Biolabs to Participate at ESCMID Global 2024 [Yahoo! Finance]
4/16
07:30 am
vrax
Virax Biolabs to Participate at ESCMID Global 2024
Medium
Report
Virax Biolabs to Participate at ESCMID Global 2024
3/15
04:41 pm
vrax
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency [Yahoo! Finance]
Low
Report
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency [Yahoo! Finance]
3/15
04:30 pm
vrax
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Low
Report
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency